| scholarly article | Q13442814 |
| P356 | DOI | 10.1164/AJRCCM.156.5.9610064 |
| P953 | full work available online at | https://www.atsjournals.org/doi/pdf/10.1164/ajrccm.156.5.9610064 |
| P698 | PubMed publication ID | 9372648 |
| P50 | author | Luis Manuel Teran | Q77321860 |
| P2093 | author name string | A. P. Kaplan | |
| S. T. Holgate | |||
| A. Janezic | |||
| A. J. Frew | |||
| K. S. Bodey | |||
| P2860 | cites work | Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils | Q24293111 |
| Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES | Q24304260 | ||
| Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant | Q28252699 | ||
| Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines | Q28253247 | ||
| Eosinophilic Inflammation in Asthma | Q29031455 | ||
| Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways | Q34137821 | ||
| RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes | Q36232134 | ||
| Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line | Q36356054 | ||
| Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8 | Q36362602 | ||
| Chemokines, leukocyte trafficking, and inflammation | Q40502969 | ||
| Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment | Q42275887 | ||
| CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status | Q43758988 | ||
| Rocket Immunoelectrophoresis | Q43824284 | ||
| Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium | Q67987669 | ||
| Lymphocyte activation in bronchoalveolar lavage and peripheral blood in atopic asthma | Q68083073 | ||
| Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes | Q70218749 | ||
| Chemokines in seasonal allergic rhinitis | Q70916216 | ||
| Safety aspects of local endobronchial allergen challenge in asthmatic patients | Q71046243 | ||
| Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients | Q71046247 | ||
| Eosinophil recruitment is associated with IL-5, but not with RANTES, twenty-four hours after allergen challenge | Q71120281 | ||
| Leukocyte recruitment after local endobronchial allergen challenge in asthma. Relationship to procedure and to airway interleukin-8 release | Q71395527 | ||
| Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects | Q72247946 | ||
| Macrophage inflammatory protein-1 alpha influences eosinophil recruitment in antigen-specific airway inflammation | Q72508283 | ||
| Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma | Q72876327 | ||
| Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1 alpha (MIP1 alpha) in bronchoalveolar lavage fluid of antigen-challenged asthmatics | Q93864382 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 1377-1383 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Release of RANTES, MIP-1 alpha, and MCP-1 into asthmatic airways following endobronchial allergen challenge | |
| Release of RANTES, MIP-1 α , and MCP-1 into Asthmatic Airways Following Endobronchial Allergen Challenge | |||
| P478 | volume | 156 |
| Q38941097 | A polymorphism in the CCL2 chemokine gene is associated with asthma risk: a case-control and a family study in Tunisia |
| Q37043414 | Allergy Enhances Neurogenesis and Modulates Microglial Activation in the Hippocampus. |
| Q44373599 | Altered intracellular expression of the chemokines MIP-1alpha, MIP-1beta and IL-8 by peripheral blood CD4+ and CD8+ T cells in mild allergic asthma |
| Q41562664 | Asthma: A Dynamic Disease of Inflammation and Repair |
| Q35684900 | Blocking cyclophilins in the chronic phase of asthma reduces the persistence of leukocytes and disease reactivation. |
| Q33899296 | CCL chemokines and asthma |
| Q34432950 | CCL2 release by airway smooth muscle is increased in asthma and promotes fibrocyte migration. |
| Q42425233 | CCL26-targeted siRNA treatment of alveolar type II cells decreases expression of CCR3-binding chemokines and reduces eosinophil migration: implications in asthma therapy |
| Q34789093 | CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation |
| Q34575325 | Chemokine receptors: multifaceted therapeutic targets |
| Q33750668 | Chemokines and allergic disease. |
| Q33753439 | Chemokines and asthma: redundancy of function or a coordinated effort? |
| Q37721300 | Chemokines and their receptors in the allergic airway inflammatory process. |
| Q24791266 | Chemokines and their role in airway hyper-reactivity |
| Q35313078 | Chemokines in the limbal form of vernal keratoconjunctivitis |
| Q36179418 | Chitin elicits CCL2 from airway epithelial cells and induces CCR2-dependent innate allergic inflammation in the lung |
| Q35902344 | Ciclesonide inhibits TNFα- and IL-1β-induced monocyte chemotactic protein-1 (MCP-1/CCL2) secretion from human airway smooth muscle cells. |
| Q28389210 | Combustion-generated nanoparticulates in the El Paso, TX, USA / Juarez, Mexico Metroplex: their comparative characterization and potential for adverse health effects |
| Q42476082 | Contrasting roles for RANTES and macrophage inflammatory protein-1 alpha (MIP-1 alpha) in a murine model of allergic peritonitis |
| Q48103055 | Critical involvement of atypical chemokine receptor CXCR7 in allergic airway inflammation |
| Q22253300 | Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes |
| Q35648173 | Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies |
| Q35561670 | Cytokine-directed therapies for the treatment of chronic airway diseases |
| Q33717312 | Cytokines in asthma |
| Q50909736 | Decreased T-bet expression and changes in chemokine levels in adults with asthma |
| Q37299303 | Differential association of plasma monocyte chemoattractant protein-1 with systemic inflammatory and airway remodeling biomarkers in type-2 diabetic patients with and without asthma |
| Q40555886 | Double-stranded RNA activates RANTES gene transcription through co-operation of nuclear factor-kappaB and interferon regulatory factors in human airway epithelial cells |
| Q33866414 | Early phase resolution of mucosal eosinophilic inflammation in allergic rhinitis |
| Q42225465 | Effects of steroid treatment on lung CC chemokines, apoptosis and transepithelial cell clearance during development and resolution of allergic airway inflammation. |
| Q28393919 | Eosinophils in fungus-associated allergic pulmonary disease |
| Q36059786 | Eosinophils in the pathogenesis of allergic airways disease. |
| Q34276341 | Evidence that formation of vimentin mitogen-activated protein kinase (MAPK) complex mediates mast cell activation following FcεRI/CC chemokine receptor 1 cross-talk. |
| Q38070582 | Experimental advances in understanding allergic airway inflammation |
| Q35856182 | Expression of YKL-40 and MIP-1a proteins in exudates and transudates: biomarkers for differential diagnosis of pleural effusions? A pilot study |
| Q33713360 | Extracellular cyclophilin levels associate with parameters of asthma in phenotypic clusters |
| Q42024863 | Gene - Gene Interactions Among MCP Genes Polymorphisms in Asthma |
| Q36226525 | HIF-1 expression is associated with CCL2 chemokine expression in airway inflammatory cells: implications in allergic airway inflammation. |
| Q48106917 | Human CCL5 trimer: expression, purification and initial crystallographic studies. |
| Q37249746 | IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production |
| Q40652292 | Induction of Regulated upon Activation, Normal T Cells Expressed and Secreted (RANTES) and Transforming Growth Factor-β1 in Airway Epithelial Cells by Mycoplasma pneumoniae |
| Q59329651 | Influence of viral infection on the relationships between airway cytokines and lung function in asthmatic children |
| Q44805067 | Inhibition of stem cell factor reduces pulmonary cytokine levels during allergic airway responses |
| Q38821886 | Intratracheal myriocin enhances allergen-induced Th2 inflammation and airway hyper-responsiveness |
| Q77579713 | Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation |
| Q28211059 | Macrophage inflammatory protein-1 |
| Q35625099 | Mixed-effects model of epithelial-mesenchymal transition reveals rewiring of signaling networks |
| Q37305676 | Moderate aerobic exercise alters migration patterns of antigen specific T helper cells within an asthmatic lung |
| Q33569149 | Neutrophil-mediated IL-6 receptor trans-signaling and the risk of chronic obstructive pulmonary disease and asthma |
| Q34529798 | New Twists to an Old Story: Novel Concepts in the Pathogenesis of Allergic Eye Disease |
| Q41761245 | Ragweed-allergic subjects have decreased serum levels of chemokines CCL2, CCL3, CCL4 and CCL5 out of the pollen season |
| Q35816421 | Recruited alveolar macrophages, in response to airway epithelial-derived monocyte chemoattractant protein 1/CCl2, regulate airway inflammation and remodeling in allergic asthma |
| Q61919378 | Replenishment of RANTES mRNA expression in activated eosinophils from atopic asthmatics |
| Q34734980 | Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation |
| Q39416927 | Serum Chemokines RANTES and Monocyte Chemoattractant Protein-1 in Egyptian Patients with Atopic Asthma: Relationship to Disease Severity |
| Q30311027 | Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung |
| Q48384283 | Sleep quality and immune mediators in asthmatic children |
| Q77347904 | Subjects with mild and moderate asthma respond to segmental allergen challenge with similar, reproducible, allergen-specific inflammation |
| Q28305039 | Temporal production of CCL28 corresponds to eosinophil accumulation and airway hyperreactivity in allergic airway inflammation |
| Q33977232 | The pathology of chronic asthma |
| Q34206328 | The role of the CCL2/CCR2 axis in mouse mast cell migration in vitro and in vivo |
| Q37255343 | Transcriptional regulation of monocyte chemotactic protein-1 release by endothelin-1 in human airway smooth muscle cells involves NF-kappaB and AP-1 |
| Q47713313 | β2-Adrenoceptor signaling in airway epithelial cells promotes eosinophilic inflammation, mucous metaplasia, and airway contractility |
Search more.